BACKGROUND: We investigated the association between diabetes mellitus (DM) and all-cause mortality in a large cohort of consecutive patients treated with primary percutaneous coronary intervention (PPCI) in the contemporary era. METHODS: We conducted a retrospective analysis of a single-centre registry of patients undergoing PPCI for ST-segment elevation myocardial infarction (STEMI) at a large regional PCI centre between 2005 and 2009. All-cause mortality in relation to patient and procedural characteristics was compared between patients with and without DM. RESULTS: Of 2586 patients undergoing PPCI, 310 (12%) had DM. Patients with DM had a higher prevalence of multi-vessel coronary disease (p<0.001) and prior myocardial infarction (p<0.001). Patients with DM were less commonly admitted directly to the interventional centre (p=0.002). Symptom-to-balloon (p<0.001) and door-to-balloon time (p=0.002) were longer in patients with DM. Final infarct-related-artery TIMI-flow grade was lower in patients with DM (p=0.031). All-cause mortality at 30 days (p=0.0025) and 1 year (p<0.0001) was higher in patients with DM. DM was independently associated with increased mortality after multivariate adjustment for potential confounders. CONCLUSIONS: Mortality remains substantially higher in patients with DM following reperfusion for STEMI in comparison with those without diabetes, despite contemporary management with PPCI. Greater co-morbidity, delayed presentation, longer times-to-reperfusion, and less optimal reperfusion may contribute to adverse outcomes.
BACKGROUND: We investigated the association between diabetes mellitus (DM) and all-cause mortality in a large cohort of consecutive patients treated with primary percutaneous coronary intervention (PPCI) in the contemporary era. METHODS: We conducted a retrospective analysis of a single-centre registry of patients undergoing PPCI for ST-segment elevation myocardial infarction (STEMI) at a large regional PCI centre between 2005 and 2009. All-cause mortality in relation to patient and procedural characteristics was compared between patients with and without DM. RESULTS: Of 2586 patients undergoing PPCI, 310 (12%) had DM. Patients with DM had a higher prevalence of multi-vessel coronary disease (p<0.001) and prior myocardial infarction (p<0.001). Patients with DM were less commonly admitted directly to the interventional centre (p=0.002). Symptom-to-balloon (p<0.001) and door-to-balloon time (p=0.002) were longer in patients with DM. Final infarct-related-artery TIMI-flow grade was lower in patients with DM (p=0.031). All-cause mortality at 30 days (p=0.0025) and 1 year (p<0.0001) was higher in patients with DM. DM was independently associated with increased mortality after multivariate adjustment for potential confounders. CONCLUSIONS: Mortality remains substantially higher in patients with DM following reperfusion for STEMI in comparison with those without diabetes, despite contemporary management with PPCI. Greater co-morbidity, delayed presentation, longer times-to-reperfusion, and less optimal reperfusion may contribute to adverse outcomes.
Authors: Mayra Tisminetzky; Samuel Joffe; David D McManus; Chad Darling; Joel M Gore; Jorge Yarzebski; Darleen Lessard; Robert J Goldberg Journal: Diab Vasc Dis Res Date: 2014-03-11 Impact factor: 3.291
Authors: Ioanna Kosmidou; Björn Redfors; Aaron Crowley; Bernard Gersh; Shmuel Chen; José M Dizon; Monica Embacher; Roxana Mehran; Ori Ben-Yehuda; Gary S Mintz; Gregg W Stone Journal: Clin Cardiol Date: 2017-07-11 Impact factor: 2.882
Authors: Francesca R Elwen; Alice Huskinson; Linda Clapham; Matthew J Bottomley; Simon R Heller; Cathryn James; Afroze Abbas; Paul Baxter; Ramzi A Ajjan Journal: BMJ Open Diabetes Res Care Date: 2015-06-30
Authors: Awsan Noman; Karthik Balasubramaniam; M Hafez A Alhous; Kelvin Lee; Peter Jesudason; Muhammad Rashid; Mamas A Mamas; Azfar G Zaman Journal: Catheter Cardiovasc Interv Date: 2016-12-28 Impact factor: 2.692